Area of research
Pulmonary and Respiratory Medicine
Research interest
Research interests include Neonatal Respiratory Health Research, Respiratory Support and Mechanisms, Inhalation and Respiratory Drug Delivery, and Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis.
Altered cholesterol immunometabolism activates the macrophage NLRP3-inflammasome in lung fibrosis
Cell Surface RNA Expression Modulates Alveolar Epithelial Function
Neutrophil-chemoattractant CXCL5 increases lung barrier permeability in acute lung injury
Enzymatic Modulation of the Pulmonary Glycocalyx Enhances Susceptibility to <i>Streptococcus pneumoniae</i>
Human alveolar progenitors generate dual lineage bronchioalveolar organoids
Metabolic Glycoengineering Enables the Ultrastructural Visualization of Sialic Acids in the Glycocalyx of the Alveolar Epithelial Cell Line hAELVi
On Top of the Alveolar Epithelium: Surfactant and the Glycocalyx
Alveolar Dynamics and Beyond – The Importance of Surfactant Protein C and Cholesterol in Lung Homeostasis and Fibrosis
Surfactant dysfunction and alveolar collapse are linked with fibrotic septal wall remodeling in the TGF-β1-induced mouse model of pulmonary fibrosis
The FMS-like tyrosine kinase-3 ligand/lung dendritic cell axis contributes to regulation of pulmonary fibrosis
Surfactant Protein B Deficiency Induced High Surface Tension: Relationship between Alveolar Micromechanics, Alveolar Fluid Properties and Alveolar Epithelial Cell Injury
Alveolar Micromechanics in Bleomycin-induced Lung Injury
iPSC-Derived Macrophages Effectively Treat Pulmonary Alveolar Proteinosis in Csf2rb-Deficient Mice
Surfactant replacement therapy reduces acute lung injury and collapse induration-related lung remodeling in the bleomycin model
Aging exacerbates acute lung injury-induced changes of the air-blood barrier, lung function, and inflammation in the mouse
Lung surfactant metabolism: early in life, early in disease and target in cell therapy
Surfactant dysfunction during overexpression of TGF-β1 precedes profibrotic lung remodeling in vivo
Human Pulmonary Surfactant Protein SP-A1 Provides Maximal Efficiency of Lung Interfacial Films
Linking progression of fibrotic lung remodeling and ultrastructural alterations of alveolar epithelial type II cells in the amiodarone mouse model
Structure-function relationships in pulmonary surfactant membranes: From biophysics to therapy
Alveolar Derecruitment and Collapse Induration as Crucial Mechanisms in Lung Injury and Fibrosis